Asthma News: Breaking Asthma News, Comments and Articles. - Page: 5

14:49 EDT 4th September 2015 | BioPortfolio

Asthma News - Page: 5Twitter RSS

Read the latest Asthma News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Asthma.

Search or Follow Our Asthma - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Asthma - Page: 5 News.
You can also follow our Asthma - Page: 5 news stories on Twitter: @asthma_bio

Showing "asthma" News Articles 101 to 125 of 946

Wednesday 5th August 2015

Even if severe allergic reaction is in doubt, epinephrine should be used

(American College of Allergy, Asthma, and Immunology) An expert panel assembled by the American College of Allergy, Asthma and Immunology agrees that even when emergency physicians aren't 100 percent sure a person is suffering from a severe allergic ...

Pharmaxis, Synairgen collaborate on pulmonary fibrosis treatment

Pharmaxis Limited (ASX:PXS) has entered into a research collaboration with UK biotechnology company Synairgen plc (LSE:SNG) to develop a treatment for the fatal lung disease idiopathic pulmonary fibrosis (IPF).    Synairgen is a specia...

Hydra Biosciences Appoints Leading Pulmonary Experts to Newly Created Medical Advisory Board

Hydra Biosciences, a leader in the field of Transient Receptor Potential (TRP) ion channel modulation in the areas of pain, inflammation, renal disease, anxiety and pulmonary disease, today announced the formation of a Pulmonary Medical Advisory Board. Three leading experts in pulmonary medicine, Dr. William Busse, Dr. Paul O’Byrne and Dr. Sven-Erik Dahl...

Kolltan Pharmaceuticals Appoints Ronald A. Peck, M.D., Chief Medical Officer and SVP, Clinical Development

-New Executive Brings Substantial Track Record in Oncology and Novel Immuno-Oncology Drug Development and Commercialization -Carolyn Sidor, M.D., Continues as an Advisor to the Company Kolltan Pharmaceuticals, Inc. (“Kolltan” or the “Company”), a privately held clinical-stage company focused on the discovery and development of novel, b...

Union Pacific Recognized as a Best Employer for Healthy Lifestyles

OMAHA, Neb., Aug. 5, 2015 /PRNewswire/ -- Union Pacific was named among the Best Employers for Healthy Lifestyles for 2015 by The National Business Group on Health (NBGH). Recognized at the gold level, Union Pacific was honored for making cultural and environmental changes, and developing comprehensive programs that support employees' healthy lifestyle goals. The company was the only railro...

Drug Device Combination Products Market Will Report a Market Value Worth US$115 Billion by 2019: Transparency Market Research

ALBANY, New York, August 5, 2015 /PRNewswire/ -- A recent study by Transparency Market Research (TMR) forecasts that the global drug device combination products market will grow at a CAGR of 7.9% between the years 2013 to 2019. TMR, a market intelligence firm based in the United States, in its report says that the global drug device combination products market which was valued at US$66 billion in...

Statement on Clean Power Plan by Emerald Cities Collaborative President and CEO Denise Fairchild

WASHINGTON, Aug. 5, 2015 /PRNewswire-USNewswire/ -- "Reducing carbon emissions to meet the requirements of EPA's Clean Power Plan will literally bring a breath of fresh air to minority and low-income communities that are plagued with higher rates of cancer, respiratory diseases such as asthma and other pollution-related illness. And as states increase their use of energy efficiency and renewable e...

Tuesday 4th August 2015

American Humane Association President & CEO Dr. Robin Ganzert To Detail New Model For Ethically And Responsibly Advancing Health Of Both Humans And Animals

VALENCIA, Spain, Aug. 5, 2015 /PRNewswire-USNewswire/ -- Dr. Robin Ganzert, president and CEO of American Humane Association, which for 138 years has led the way in developing protections for children, pets, and farm animals, is the keynote speaker and session chair at the Third International Conference on Epidemiology and Public Health in Valencia, Spain today. Her address, "A New Medical Re...

Adherium launches IPO prior to ASX listing

Adherium, a manufacturer of digital health technologies that address suboptimal medication use in chronic diseases, is seeking to raise a maximum of $35 million in the lead-up to its listing on the ASX. In an IPO which is expected to run until 14 August, the company will issue up to 70 million shares at $0.50 per share. Adherium intends to use the proceeds of the IPO to supply commercial quantiti...

Project Sunshine and UnitedHealth Group Bring Beach Party to East Harlem Asthma Center of Excellence

Children’s Author and Sesame Street Alumna Sonia Manzano joined in activities; gave EHACE’s young members signed copies of her children’s book “No Dogs Allowed” Children’s book author Sonia Manzano, who played Maria on Sesame Street, joined UnitedHealth Group volunteers at Project Sunshine’s “Party Time” event at t...

Exploring 'clinical conundrum' of asthma-COPD overlap in nonsmokers with chronic asthma

(American College of Chest Physicians) Researchers may be closer to finding the mechanism responsible for loss of lung elastic recoil and airflow limitation in nonsmokers with chronic asthma. The study published today in the journal CHEST Unraveling ...

Matthew Korenberg to Join Ligand Pharmaceuticals as Chief Financial Officer

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the appointment of Matthew Korenberg as Vice President, Finance and Chief Financial Officer. Mr. Korenberg is expected to join Ligand’s management team on August 6th. Mr. Korenberg joins Ligand from NeuroCircuit Therapeutics, a developer of drugs to treat genetic disorders affecting th...

Nanoparticles Breach Mucus Barrier in Lungs

Researchers at the Johns Hopkins University School of Medicine, Johns Hopkins University Department of Chemical and Biomolecular Engineering, and Federal University of Rio de Janeiro in Brazil have designed a DNA-loaded nanoparticle that can pass thr...

Xencor Reports Second Quarter 2015 Financial and Operating Results

MONROVIA, Calif., Aug. 4, 2015 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today reported financial results for the second quarter ended June 30, 2015 and provided a review of its business highlights. "Currently eight...

GSK to strengthen social media presence with Wunderman

Biospectrum The pharma giant has tapped Wunderman Philippines to lead work for the Health.gsk website and the advocacy initiatives “Win Against Asthma” and “Power ...

Pharmacists in Focus: Point-of-Dispensing Adherence Interventions

A challenge faced globally by health professionals lies in encouraging patients prescribed medication to better understand their treatment and disease, as well as to take it in the right dose and at the right time. According to Dr Grace Lomax, Co-Fou...

Technology allows patients, caregivers to manage care with less stress

There's no substitute for good communication when it comes to managing chronic health problems like heart failure, diabetes or asthma.

Xencor to Present at 2015 Wedbush PacGrow Healthcare Conference

MONROVIA, Calif., August 4, 2015 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced that John Desjarlais, Ph.D., Senior Vice President, Research and Chief Scientific Officer, will present at the 2015 Wedbush PacGrow Hea...

Teen marijuana use not linked to later depression, lung cancer, other health problems, study finds

Chronic marijuana use by teenage boys does not appear to be linked to later physical or mental health issues such as depression, psychotic symptoms or asthma, according to a study published by the American Psychological Association.

Regeneron Reports Second Quarter 2015 Financial and Operating Results

TARRYTOWN, N.Y., Aug. 4, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the second quarter of 2015 and provided an update on development programs. Financial Highlights ($ in millions, except per share data) Three Months Ended

Unjamming and cell shape in the asthmatic airway epithelium

Cell shape provides a structural signature for the classification and investigation of the jamming of bronchial epithelial layers in asthma.

Monday 3rd August 2015

Romark Laboratories and Lupin Pharmaceuticals Respond to Recent Cryptosporidium (Crypto) Outbreak in Knoxville

TAMPA, FL and BALTIMORE, MD -- (Marketwired) -- 08/04/15 -- Two pharmaceutical companies with expertise in infectious diseases today responded to an outbreak of cryptosporidiosis (Crypto), an illness spread through swimming pools, water parks and lakes, in Knoxville, Tennessee. Romark Laboratories is a Tampa-based pharmaceutical company committed to the discovery, development and commercializati...

Allergy & Asthma Network Applauds Clean Power Plan

VIENNA, Va., Aug. 3, 2015 /PRNewswire-USNewswire/ -- Allergy & Asthma Network, the leading nonprofit patient education and advocacy organization, announced its strong support for the Clean Power Plan, a new initiative that will help combat climate change and reduce pollutants that can impact everyone, especially those vulnerable to dangerous chronic health conditions such as asthma. The Clean...

On-Chip Processor the First Step in Point-of-Care Tuberculosis and Asthma Diagnostics

A device to mix liquids utilizing ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma. The device, developed by engineers at Penn State in collaboration with researchers at the National Heart, Lung, and Blood Institute

Harvey Dental Launches New Cavity-Fighting Program for the Waupaca Community

Harvey Dental now offers patients a new model for health and prevention Waupaca, Wisconsin (PRWEB) August 03, 2015 According to the CDC, dental caries (cavities) are at epidemic levels in the United States and although it is largely preventable, it remains the most common chronic disease of children aged 5-17 years (4 times more common than asthma). Frustration for both patients and dental prof...



Advertisement
 
Advertisement
 

News Quicklinks